Clinical trial
Slow-release CArvedilol in Patients With REduced Strain and Preserved Ejection Fraction Heart Failure (CARE-preserved HF): A Prospective Randomized, Double-Blinded, Multicenter Study
NCT05553314 is registered in ClinicalTrials.gov with Seoul National University Bundang Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Slow-release CArvedilol in Patients With REduced Strain and Preserved Ejection Fraction Heart Failure (CARE-preserved HF): A Prospective Randomized, Double-Blinded, Multicenter Study
- Lead sponsor
- Seoul National University Bundang Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 17, 2021
- Completion date
- January 8, 2026
- Enrollment
- 63 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
beta blocker, heart failure with preserved ejection fraction, myocardial strain